| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.24 | 6e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.17 | 0.0003 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.095 | 0.04 |